Anthracycline cardiotoxicity prevention by dexrazoxane: breakthrough of a barrier--sharpens antitumor profile and therapeutic index.
Hellmann
K
K
D000328:Adult; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002648:Child; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D011929:Razoxane / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D002317:Cardiovascular Agents; D011929:Razoxane